Literature DB >> 28951332

Involvement of glucose-regulated protein 78 and spliced X-box binding protein 1 in the protective effect of gliclazide in diabetic nephropathy.

Ying-Wen Zhang1, Xiuping Wang2, Xiaodan Ren2, Manling Zhang2.   

Abstract

AIMS: To testing whether endoplasmic reticulum (ER) stress contributes to the development of diabetic nephropathy. Investigated the effect of gliclazide, an oral antihyperglycemic agent, in a rat model of diabetic nephropathy and the underlying mechanism related to the ER stress response.
METHODS: Sixty SD rats were divided into six groups. Diabetic nephropathy was induced in 30 rats with a streptozotocin (STZ) injection and high fat diet, which were then treated with saline, gliclazide or 4-PBA. 20 rats were treated with Tunicamycin (TM) one-time intraperitoneal injection, following treated with saline or gliclazide. Blood glucose, kidney index and function were evaluated. Light and transmission electron microscopy (TEM) were used to observe kidney histological changes. Quantitative real-time PCR and western blot were performed to access the mRNA and protein levels of glucose-regulated protein 78 (GRP78) and spliced X-box binding protein 1 (sXBP1) in glomeruli. RESULT: STZ-induced diabetic rats evidenced nephropathy by higher serum creatinine (sCr), blood urea nitrogen (BUN), microalbuminuria (MAU), and kidney index. Histological examination and TEM assay showed abnormal renal structures including thick glomerular basement membrane and mesangial cell expansion. The same changes were found in TM-treated rats. Gliclazide-treated had similar kidney index, but lower glucose levels, sCr, BUN, and MAU, compared with both saline and 4-PBA-treated diabetic rats or saline-treated TM rats. Synchronize with significantly lower Grp78 and sXbp1 mRNA and protein levels.
CONCLUSION: Diabetes-induced nephropathy is associated with ER stress. Gliclazide treatment lessens diabetic nephropathy, probably partially by suppressing the GRP78- and sXBP1-mediated ER response.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diabetic nephropathy; ER stress; GRP78; Gliclazide; XBP1

Mesh:

Substances:

Year:  2017        PMID: 28951332     DOI: 10.1016/j.diabres.2017.04.019

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  3 in total

1.  Effects of insulin-like growth factor-1 on endoplasmic reticulum stress and autophagy in rat gastric smooth muscle cells cultured at different glucose concentrations in vitro.

Authors:  Xue-Sen Fang; Mo-Han Zhang; Jun-Yu Guo; Zheng Jin
Journal:  Mol Cell Biochem       Date:  2018-07-14       Impact factor: 3.396

2.  XBP1 inhibits mesangial cell apoptosis in response to oxidative stress via the PTEN/AKT pathway in diabetic nephropathy.

Authors:  Yan Wang; Zhong He; Qiu Yang; Guangju Zhou
Journal:  FEBS Open Bio       Date:  2019-06-02       Impact factor: 2.693

3.  Combination Therapy of Alpha-Lipoic Acid, Gliclazide and Ramipril Protects Against Development of Diabetic Cardiomyopathy via Inhibition of TGF-β/Smad Pathway.

Authors:  George J Dugbartey; Quinsker L Wonje; Karl K Alornyo; Louis Robertson; Ismaila Adams; Vincent Boima; Samuel D Mensah
Journal:  Front Pharmacol       Date:  2022-03-21       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.